948 Results

People

  1. Kris
    Kris
  2. Kelsen
    Kelsen
  3. Motzer
    Motzer
  4. O'Reilly
    O'Reilly
  5. Saltz
    Saltz
  6. Tyson
    Tyson
  7. Gralla
    Gralla
  8. Hudis
    Hudis
  9. Scher
    Scher
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)
  7. Center for Hematologic Malignancies (109)
  8. Genitourinary Oncology Service (106)
  9. Nursing (101)
  10. Surgery (97)
  1. "vomiting"
Formats
  1. Journal Article (896)
  2. Review (27)
  3. Conference Paper (8)
  4. Editorial (6)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Guidelines (2)
  8. Book Section (1)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)

More Groups

People
  1. Mark Kris (70)
  2. David Kelsen (40)
  3. Robert Motzer (39)
  4. Eileen O'Reilly (30)
  5. Leonard Saltz (30)
  6. Leslie Tyson (28)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (44)
  4. 2022 (32)
  5. 2021 (15)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Cancer (47)
  3. Clinical Cancer Research (44)
  4. Lancet Oncology (38)
  5. Gynecologic Oncology (31)
  6. Cancer Treatment Reports (26)

More Publications

Publishers
  1. Elsevier Inc. (145)
  2. American Society of Clinical Oncology (92)
  3. Elsevier Science, Inc. (74)
  4. Springer (72)
  5. Oxford University Press (64)
  6. Wiley Blackwell (63)

More Publishers

Results (948)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and radiographic presentations of COVID-19 among patients receiving radiation therapy for thoracic malignancies
    Journal Article

    Samson, P.; Ning, M. S.; Shaverdian, N.; Shepherd, A. F.; Gomez, D. R.; McGinnis, G. J.; Nitsch, P. L.; Chmura, S.; O'Reilly, M. S.; Lee, P.; more...
    Advances in Radiation Oncology (2020)

    Fulltext@MSK | Save
  • Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
    Journal Article

    Ikeda, T.; Takemoto, S.; Senju, H.; Gyotoku, H.; Taniguchi, H.; Shimada, M.; Dotsu, Y.; Umeyama, Y.; Tomono, H.; Kitazaki, T.; more...
    Thoracic Cancer (2020)

    Fulltext@MSK | Save
  • Current knowledge and research priorities in the digestive manifestations of COVID-19
    Review

    Aroniadis, O. C.; DiMaio, C. J.; Dixon, R. E.; Elmunzer, B. J.; Kolb, J. M.; Mendelsohn, R.; Ordiah, C. O.; Rockey, D. C.; Singal, A. G.; Spitzer, R. L.; more...
    Clinical Gastroenterology and Hepatology (2020)

    Fulltext@MSK | Save
  • Management of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah’s Witness
    Journal Article

    Rubinstein, M. M.; Goss, C.; Avecilla, S. T.; Dubé, G. P.; Riely, G. J.; Mones, J. V.
    Clinical Case Reports (2020)

    Fulltext@MSK | Save
  • DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
    Journal Article

    Wudhikarn, K.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; Shah, G. L.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Consensus recommendations for management and counseling of adverse events associated with lorlatinib: A guide for healthcare practitioners
    Guidelines

    Reed, M.; Rosales, A. L. S.; Chioda, M. D.; Parker, L.; Devgan, G.; Kettle, J.
    Advances in Therapy (2020)

    Fulltext@MSK | Save
  • Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
    Journal Article

    Goldberg, A. D.; Atallah, E.; Rizzieri, D.; Walter, R. B.; Chung, K. Y.; Spira, A.; Stock, W.; Tallman, M. S.; Cruz, H. G.; Boni, J.; more...
    Leukemia Research (2020)

    Fulltext@MSK | Save
  • Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: A multicentre, open-label, phase 1 study
    Journal Article

    Tan, D. S. W.; Leighl, N. B.; Riely, G. J.; Yang, J. C. H.; Sequist, L. V.; Wolf, J.; Seto, T.; Felip, E.; Aix, S. P.; Jonnaert, M.; more...
    The Lancet Respiratory Medicine (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Donning a new approach to the practice of gastroenterology: Perspectives from the COVID-19 pandemic epicenter
    Review

    Sethi, A.; Swaminath, A.; Latorre, M.; Behin, D. S.; Jodorkovsky, D.; Calo, D.; Aroniadis, O.; Mone, A.; Mendelsohn, R. B.; Sharaiha, R. Z.; more...
    Clinical Gastroenterology and Hepatology (2020)

    Fulltext@MSK | Save